Invasive multidisciplinary management of GEP NETs: scopes, knives, needles and robots

Location
Mercure holland house hotel
24-26 Newport Road
Cardiff

Surgical management of NET patients remains exceedingly challenging although it continues to provide hope of cure and prolonged survival for some of our patients. Decision making on when to operate is dependent on specialist knowledge and shared expertise of multi-disciplinary NET teams. Surgery may not be appropriate and/or necessary even when there is possibility of a cure. Alternatively, surgery may be necessary to tackle particular issues even when possibility of cure does not exist. Another challenge we face is whether to offer resection of a primary when there are significant distal metastases. There has been substantial improvement in our ability to stage neuroendocrine tumours that is guiding decision making for surgery. Furthermore, clinical trials are being setup to help us improve outcomes with surgery. The 2024 symposium will highlight the challenges and possible solutions.

This meeting is for people making decisions on treatments for patients with NETs. This meeting is important for regional Cancer Alliances, Specialist Commissioners, and the HPB and Colorectal Expert Advisory Groups whose members are often responsible for the initial care of patients with NETs. The delegates will achieve a good understanding of the present role of surgery and the availability of surgical and associated expertise around the UK. The symposium will help develop a national strategy for surgery in patients with NETs.

Full programme available here…

Invasive multidisciplinary management of GEP NETs: scopes, knives, needles and robots

Tuesday 3rd December 2024 – From 08:30am – 17:00pm

 

08:30 – 08:50                           Registration and Refreshments

08:50 – 09:00                           Welcome (Tahir Shah and Stacey Smith)

09:00 – 09:45                           Rectal NETs (Chair: TBC)

09:00 – 09:15                  Growing incidence and Endoscopic management/follow up (Raj Srirajaskanthan)

09:15 – 09:30                  Implementing ENETS guidelines into NHS practice (Dalvinder Mandair)

09:30 – 09:45                  Staging and surgical strategies (Hamish Clouston)

 

09:45 – 10:35                           Small Intestinal NETs (Chair: Alia Munir & TBC)

 

09:45 – 10:00                  SI primary resection- Achieving clearance with curative intent (Surgeon from Italy TBC)

10:00 – 10:15                  Surgical technique/indication for Minimally invasive surgery (Nuha Yassin)

10:15 – 10:30                  Complex Small Intestinal NETs: is there a role for small bowel or multi-visceral

Transplantation?  (Emilio Canovai)

10:30 – 10:35                 Possible trials (Samuel Ford)

10:35 – 10:45                           Coffee Break

10:45 – 12:00                           Pancreas (Chair: Wendy Martin & Bobby Dasari)

10:45 – 11:00                  Indications for surgery (Stuart Robinson)

11:00 – 11:15                  Role of ablation in PNETs (Brin Mahon)

11:15 – 11:30                  Surgical strategy in gastrinoma/MEN-1 and VHL (Andrea Frilling)

11:30 – 11:45                  Whipple’s – should it ever be performed when liver metastases present? (Bobby Dasari)

11:45 – 12:00                  Overall strategy, prognosis and QoL following major pancreatic surgery (Brian Davidson)

 

12:00 – 12:45                           Management of Gastric NETs (Chairs: Mark Pritchard and Samuel Ford)

12:00 – 12:15                  Overview (Mark Pritchard)

12:15 – 12:30                  Surgical resection: when/extent of surgery (Nathan Stephens)

12:30 – 12:45                  Endoscopic management (Brin Mahon)

 

12:45 – 13:30                           Lunch

 

13:30 – 15:30                           Liver metastases (Chair:  Stuart Robinson and Brian Davidson)

13:30 – 13:45                  Is there ever a role for ablation? (Nabil Kibriya)

13:45 – 14:00                  Indications and practicalities of bland/chemo and radioembolisation liver metastases (Brian Stedman)

14:00 – 14:15                  Surgical strategy for cytoreductive surgery: timing, indications, technique (Tom Armstrong)

14:15 – 14:30                  Control carcinoid syndrome prior to surgery (Raj Srirajaskanthan)

14:30 – 14:45                  Clinical trials (Andrea Frilling)

14:45 – 15:00                  Liver transplantation (Tahir Shah)

15:00 – 15:30                  Expanding criteria for liver transplantation, the Milan experience (Vincenzo Mazzaferro)

 

15:30 – 15:45                           Coffee Break

 

15:45 – 16:00                           Safe perioperative practices (Samuel Denham) (Chairs: Tahir Shah and Stacey Smith)

 

16:00 – 16:15                           Role of NET CNS in management of patients undergoing surgery (Suzanne Vickrage)

(Chairs: Tahir Shah and Stacey Smith)

 

16:15 – 17:00                           General Discussion about surgical representation at MDTs in CoEs- Panel discussion

(All speakers) (Chairs: Tahir Shah and Stacey Smith)

 

1700                                         Close

Back to list

Loading Map....

Latest news